0001103021-19-000037.txt : 20191119
0001103021-19-000037.hdr.sgml : 20191119
20191119163652
ACCESSION NUMBER: 0001103021-19-000037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191118
FILED AS OF DATE: 20191119
DATE AS OF CHANGE: 20191119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Plesha Scott M.
CENTRAL INDEX KEY: 0001726687
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31361
FILM NUMBER: 191231748
MAIL ADDRESS:
STREET 1: 1410 SMYTHE ST
CITY: DANIEL ISLAND
STATE: SC
ZIP: 29492
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC
CENTRAL INDEX KEY: 0001103021
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 352089858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
BUSINESS PHONE: 919 582 9050
MAIL ADDRESS:
STREET 1: 4131 PARKLAKE AVENUE
STREET 2: SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27612
FORMER COMPANY:
FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP
DATE OF NAME CHANGE: 20000111
4
1
wf-form4_157419939601689.xml
FORM 4
X0306
4
2019-11-18
0
0001103021
BIODELIVERY SCIENCES INTERNATIONAL INC
BDSI
0001726687
Plesha Scott M.
C/O BIODELIVERY SCIENCES INTL, INC.,
4131 PARKLAKE AVE. SUITE 225
RALEIGH
NC
27612
0
1
0
0
See Remarks
Common Stock
2019-11-18
4
S
0
25000
6.06
D
257336
D
The shares of Common Stock were automatically sold under a pre-planned 10b5-1 trading plan.
On November 18, 2019, the Reporting Person sold an aggregate of 25,000 shares of the Issuer's Common Stock at a weighted average price of $6.06 per share. The highest sale price for the Common Stock was $6.16 per share and the lowest sale price was $6.01 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
/s/ Scott Plesha
2019-11-19